Updates on key developments in genomics
100,000 Genomes Project 2021 update: cancer
In the first instalment of a two-part series, we look at how the 100,000 Genomes Project continues to impact cancer care
Diagnosing mitochondrial conditions: a WGS breakthrough
Mitochondrial conditions can be difficult to diagnose – but why, and how can genomic technology help?
Polycystic kidney disease and genomic testing
We explore genomics’ role in the cause, diagnosis and treatment of a complex kidney condition
Covid-19 'neanderthal' gene variants explained
In light of new research, we revisit the role our genome plays in the severity of Covid-19 symptoms
NICE approves RNAi therapy for porphyria
This week, we look at the latest gene silencing treatment approved by NICE – this time for an acute form of porphyria
Reading DNA - where to start?
This week, we learn all about directionality in DNA and why it matters
World-first study shows WGS improves diagnostic journey
Impressive results make the case for the adoption of whole genome sequencing as "the genetic test of choice for rare disease patients"
Genes, hormones and blood pressure
This week, we explore genomics’ role in primary aldosteronism – a hormone disorder that leads to high blood pressure
Sequencing Covid-19: 1 million genomes
As the UK reaches a mega sequencing milestone, we look at how the data could be used to better prepare us for the future
GEP fellow publishes RNA splicing study
Jamie Ellingford and his co-authors explore the potential of computational tools to help us learn more about the messages our genes create
Epilepsy and the genome
We know that epilepsy can have a genetic cause, but there is still much to discover. We explore findings from two new studies to learn more
RNAi: a new approach to combat cholesterol
The new cholesterol drug inclisiran is currently making headlines after being approved for use in the NHS, but how does it work?
New data diversity initiative launches
This week, we look at a transformative programme that aims to rapidly make genomic datasets more representative
Screening the healthy for monogenic variants
As the NHS moves towards a preventative healthcare strategy, will genomic screening for healthy people become more common?
Parkinson's disease: understanding the cause
In light of new research, we explore the role genes and their products can play in the onset of Parkinson’s disease
Cell-free DNA: detecting disease
We look at how cfDNA could be used to diagnose LMD – a life-threatening condition that is currently difficult to detect
Covid-19: susceptibility and the genome
An international collaboration has discovered new links between our genome and the variable onset and severity of Covid-19
NHS targets better diabetes care with genomic testing
New initiative aims to find thousands of people with a rare, inherited form of diabetes
Newborn screening: time for a genomic approach?
This week, we explore how genomics could help expand the newborn screening programme to test for many more genetic conditions
PCR: more than just a Covid test
An old friend has been thrust into the limelight. We take a look at how PCR works and its place in Covid testing and beyond
Trial underway for hATTR therapy
The novel ‘one off’ treatment could change the lives of those living with the condition